180 related articles for article (PubMed ID: 14636648)
21. Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia.
Notarangelo LD; Mazza C; Giliani S; D'Aria C; Gandellini F; Ravelli C; Locatelli MG; Nelson DL; Ochs HD; Notarangelo LD
Blood; 2002 Mar; 99(6):2268-9. PubMed ID: 11877312
[TBL] [Abstract][Full Text] [Related]
22. Atypical Wiskott-Aldrich syndrome in a girl.
Conley ME; Wang WC; Parolini O; Shapiro DN; Campana D; Siminovitch KA
Blood; 1992 Sep; 80(5):1264-9. PubMed ID: 1515642
[TBL] [Abstract][Full Text] [Related]
23. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene.
Villa A; Notarangelo L; Macchi P; Mantuano E; Cavagni G; Brugnoni D; Strina D; Patrosso MC; Ramenghi U; Sacco MG
Nat Genet; 1995 Apr; 9(4):414-7. PubMed ID: 7795648
[TBL] [Abstract][Full Text] [Related]
24. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
Snapper SB; Rosen FS
Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
[TBL] [Abstract][Full Text] [Related]
25. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
[TBL] [Abstract][Full Text] [Related]
26. A novel mutation W252X in the WAS gene in a Korean patient with Wiskott-Aldrich syndrome.
Kim HJ; Yoo EH; Ki CS; Yoo GH; Koo HH; Kim JW; Kim SH
Int J Hematol; 2006 Jun; 83(5):426-8. PubMed ID: 16787874
[TBL] [Abstract][Full Text] [Related]
27. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene.
Zhu Q; Zhang M; Blaese RM; Derry JM; Junker A; Francke U; Chen SH; Ochs HD
Blood; 1995 Nov; 86(10):3797-804. PubMed ID: 7579347
[TBL] [Abstract][Full Text] [Related]
28. Detection of lymphocytes and granulocytes expressing the mutant WASP message in carriers of Wiskott-Aldrich syndrome.
Ariga T; Yamada M; Wada T; Saitoh S; Sakiyama Y
Br J Haematol; 1999 Mar; 104(4):893-900. PubMed ID: 10192456
[TBL] [Abstract][Full Text] [Related]
29. The genotype of the original Wiskott phenotype.
Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
[TBL] [Abstract][Full Text] [Related]
30. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
[TBL] [Abstract][Full Text] [Related]
31. Random X chromosome inactivation in a female with a variant of Wiskott-Aldrich syndrome.
Russell SJ; Nisen PD
Br J Haematol; 1995 May; 90(1):210-2. PubMed ID: 7786787
[TBL] [Abstract][Full Text] [Related]
32. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype.
Zhu Q; Watanabe C; Liu T; Hollenbaugh D; Blaese RM; Kanner SB; Aruffo A; Ochs HD
Blood; 1997 Oct; 90(7):2680-9. PubMed ID: 9326235
[TBL] [Abstract][Full Text] [Related]
33. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
[TBL] [Abstract][Full Text] [Related]
34. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
[TBL] [Abstract][Full Text] [Related]
35. [Molecular genetic diagnosis of Wiskott-Aldrich syndrome].
Orth U; Rosenkranz W; Schwinger E; Holzgreve W; Gal A
Monatsschr Kinderheilkd; 1993 Sep; 141(9):728-31. PubMed ID: 8413349
[TBL] [Abstract][Full Text] [Related]
36. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.
Lemahieu V; Gastier JM; Francke U
Hum Mutat; 1999; 14(1):54-66. PubMed ID: 10447259
[TBL] [Abstract][Full Text] [Related]
37. Mapping of a syndrome of X-linked thrombocytopenia with Thalassemia to band Xp11-12: further evidence of genetic heterogeneity of X-linked thrombocytopenia.
Raskind WH; Niakan KK; Wolff J; Matsushita M; Vaughan T; Stamatoyannopoulos G; Watanabe C; Rios J; Ochs HD
Blood; 2000 Apr; 95(7):2262-8. PubMed ID: 10733494
[TBL] [Abstract][Full Text] [Related]
38. Two novel mutations of Wiskott-Aldrich syndrome: the molecular prediction of interaction between the mutated WASP L101P with WASP-interacting protein by molecular modeling.
Kim MK; Kim ES; Kim DS; Choi IH; Moon T; Yoon CN; Shin JS
Biochim Biophys Acta; 2004 Oct; 1690(2):134-40. PubMed ID: 15469902
[TBL] [Abstract][Full Text] [Related]
39. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
Sasahara Y
Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
[TBL] [Abstract][Full Text] [Related]
40. Carrier detection in the Wiskott Aldrich syndrome.
Fearon ER; Kohn DB; Winkelstein JA; Vogelstein B; Blaese RM
Blood; 1988 Nov; 72(5):1735-9. PubMed ID: 3263154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
